A randomized, multicenter, double-blind, placebo-controlled, 18 month study of the efficacy of xaliproden in patients with mild to moderate dementia of the Alzheimer's type. Protocol No. EFC 2724. (2003–2008)

Grant type:
SANOFI - SYNTHELABO AUSTRALIA PTY LTD
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Sanofi - Synthelabo Australia Pty Ltd